Related Experiment Video
Updated: Jul 19, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Metabolic emergencies in diabetes
Apurba Kumar Mukherjee1, Manash Bhanja Chowdhury
1Department of Medicine, RG Kar Medical College, Kolkata.
Journal of the Indian Medical Association
|October 25, 2006
Summary
Diabetic patients on therapy commonly face hypoglycemia. Prompt diagnosis of diabetic ketoacidosis (DKA) and hyperosmolar non-ketotic state in emergencies is crucial for timely intervention and preventing severe outcomes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Emergency Medicine
Background:
- Hypoglycaemia is a frequent metabolic complication in diabetic patients undergoing hypoglycaemic therapy.
- Diabetic ketoacidosis (DKA) and hyperosmolar non-ketotic state (HNKSS) are critical hyperglycaemic emergencies requiring urgent recognition.
Purpose of the Study:
- To highlight the importance of prompt diagnosis of DKA in emergency settings.
- To describe the clinical presentation and precipitating factors of HNKSS in elderly type 2 diabetes patients.
- To briefly mention the rarity and potential causes of lactic acidosis in diabetic patients.
Main Methods:
- Clinical case review and diagnostic criteria for hyperglycaemic emergencies.
- Emphasis on urgent capillary blood glucose (CBG) and urinary ketone testing for DKA.
- Identification of key clinical features distinguishing DKA from HNKSS.
Main Results:
- DKA diagnosis necessitates urgent testing in emergency patients with dehydration, shock, coma, or respiratory distress.
- HNKSS presents with severe dehydration and hyperglycaemia, typically in elderly type 2 diabetics with infections, and lacks acidosis and vomiting.
- Lactic acidosis is rare but can be exacerbated by comorbidities and metformin use.
Conclusions:
- Early identification of DKA and HNKSS through targeted testing is vital in emergency care.
- Recognizing the distinct presentations of these hyperglycaemic emergencies improves patient management.
- Awareness of lactic acidosis triggers, including metformin, is important for preventing rare but severe complications.
Related Concept Videos
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...